When reviewers were subspeciality-trained, misclassification rates were the lowest.
UCLA professor Dr. Michelle Bholat spoke at Zócalo about the need to license more foreign-trained doctors and of how hospitals are adapting to the cultures of patients.
The lack of coordination among doctors, social workers and other health providers has been one of the health system’s longstanding challenges.
The finding suggests that predicting how a person’s cancer will evolve may lie in their inherited genetic material.
The analysis suggests that individuals who are unsheltered are far more likely to encounter problems and that the problems are exacerbated the longer they are unsheltered.
The approach could eventually be useful not only for treating cancer, but also for lipid metabolism-related conditions like diabetes.
Findings of the research conducted in mice could inform the development of therapies that reduce the time it takes for people to recover from nerve injuries.
Research brief: Blocking a protein could become a novel therapy for pulmonary fibrosis-pulmonary hypertension, which currently has no approved treatment.
A separate grant of $3.3 million will fund a study on the effectiveness of text messages for helping people adhere to their treatment regimens.
The researchers’ goal was to create a therapy that would permanently boost the body’s ability to naturally produce more iNKT cells.
Researchers developed a simulation model, which allows users to predict the care setting individuals will select, based on their characteristics.
Research brief: The findings suggest a need to change how records are kept because electronic medical records are used to inform decisions about patient care and to generate bills.
Innovative technology improves visualization of a patient’s anatomy.
UCLA Health researchers implanted a wireless device that enables people without sight to detect motion, distinguish light and dark.
The study results have the potential to establish a new standard for using this method to actively monitor prostate cancer.
At a Zócalo/UCLA event in Washington, D.C., experts discussed how technology will uncover the causes of the disease and offer new therapies.
Melioidosis claims an estimated 90,000 lives worldwide each year, but there is no vaccine, and the bacterium that causes it can usually resist even the strongest antibiotics.
The prominent cancer researcher is honored for his invention of the breast cancer drug Herceptin.
Arginase deficiency, which is caused by a missing or mutated version of the arginase gene, ARG1, affects about one of every 1 million babies in the U.S.
The study by the UCLA Center for Health Policy Research also found that “connectedness” and volunteerism varied by race and income.
Research shows that certain gut bacteria can respond to serotonin and drugs that influence serotonin, like anti-depressants. The biologists call this a unique form of communication between bacteria and cells.
Research brief: Most prescriptions began appropriately but became unnecessary because they were prescribed far longer than needed, the study found.
The software provides data to help doctors diagnose and treat back pain.
The new Biodesign Hub in Los Angeles will focus on developing medical technology and digital health tools.
A multi-disciplinary group of all-star researchers has been brought together thanks to a gift from philanthropists David and Diane Steffy.